Hassan R - Search Results

1

Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma.

Hassan R, Alley E, Kindler H, Antonia S, Jahan T, Honarmand S, Nair N, Whiting CC, Enstrom A, Lemmens E, Tsujikawa T, Kumar S, Choe G, Thomas A, McDougall K, Murphy AL, Jaffee E, Coussens LM, Brockstedt DG. Hassan R, et al. Clin Cancer Res. 2019 Oct 1;25(19):5787-5798. doi: 10.1158/1078-0432.CCR-19-0070. Epub 2019 Jul 1. Clin Cancer Res. 2019. PMID: 31263030 Free PMC article. Clinical Trial.

2

Pretreatment with rituximab does not inhibit the human immune response against the immunogenic protein LMB-1.

Hassan R, Williams-Gould J, Watson T, Pai-Scherf L, Pastan I. Hassan R, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):16-8. doi: 10.1158/1078-0432.ccr-1160-3. Clin Cancer Res. 2004. PMID: 14734446 Clinical Trial.

3

Mesothelin: a new target for immunotherapy.

Hassan R, Bera T, Pastan I. Hassan R, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3937-42. doi: 10.1158/1078-0432.CCR-03-0801. Clin Cancer Res. 2004. PMID: 15217923 Review.

4

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.

Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Ho M, et al. Among authors: hassan r. Clin Cancer Res. 2005 May 15;11(10):3814-20. doi: 10.1158/1078-0432.CCR-04-2304. Clin Cancer Res. 2005. PMID: 15897581

5

Localization of mesothelin in epithelial ovarian cancer.

Hassan R, Kreitman RJ, Pastan I, Willingham MC. Hassan R, et al. Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):243-7. doi: 10.1097/01.pai.00000141545.36485.d6. Appl Immunohistochem Mol Morphol. 2005. PMID: 16082249

6

New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.

Onda M, Willingham M, Nagata S, Bera TK, Beers R, Ho M, Hassan R, Kreitman RJ, Pastan I. Onda M, et al. Among authors: hassan r. Clin Cancer Res. 2005 Aug 15;11(16):5840-6. doi: 10.1158/1078-0432.CCR-05-0578. Clin Cancer Res. 2005. PMID: 16115924

7

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY. Yokokawa J, et al. Among authors: hassan r. Clin Cancer Res. 2005 Sep 1;11(17):6342-51. doi: 10.1158/1078-0432.CCR-05-0596. Clin Cancer Res. 2005. PMID: 16144939 Free PMC article.

8

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M. Hassan R, et al. Clin Cancer Res. 2006 Jan 15;12(2):447-53. doi: 10.1158/1078-0432.CCR-05-1477. Clin Cancer Res. 2006. PMID: 16428485

9

Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma.

Onda M, Nagata S, Ho M, Bera TK, Hassan R, Alexander RH, Pastan I. Onda M, et al. Among authors: hassan r. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4225-31. doi: 10.1158/1078-0432.CCR-06-0472. Clin Cancer Res. 2006. PMID: 16857795

10

Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice.

Zhang Y, Xiang L, Hassan R, Paik CH, Carrasquillo JA, Jang BS, Le N, Ho M, Pastan I. Zhang Y, et al. Among authors: hassan r. Clin Cancer Res. 2006 Aug 1;12(15):4695-701. doi: 10.1158/1078-0432.CCR-06-0346. Clin Cancer Res. 2006. PMID: 16899620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,104 results

Search Page